Curl Moisture Anti-dandruff Conditioner
Generic Name: curl moisture anti-dandruff conditioner
Brand Names:
Bhs Beautiful Hair And Scalp
Purpose Anti-dandruff
Overview
Purpose Anti-dandruff
Uses
Use Helps prevent and control recurrence of itching, flaking and irritation associated with dandruff.
Dosage
Directions For best results use at least twice per week or as directed by a doctor. Shake well, then massage into scalp and hair. Rinse.
Warnings
Warnings For external use only When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughtly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.
Frequently Asked Questions
What is Curl Moisture Anti-dandruff Conditioner used for?▼
Use Helps prevent and control recurrence of itching, flaking and irritation associated with dandruff.
What are the important warnings for Curl Moisture Anti-dandruff Conditioner?▼
Warnings For external use only When using this product avoid contact with eyes. If contact occurs, rinse eyes thoroughtly with water. Stop use and ask a doctor if condition worsens or does not improve after regular use of this product as directed.
Related Medications
Zinc Acetate Dihydrate Milled
zinc acetate dihydrate milled
Dosage form: POWDER. Active ingredients: ZINC ACETATE (1 kg/kg). Category: BULK INGREDIENT.
Echinacea,baptisia Tinctoria, Hydrastis Canadensis, Myrrha, Phytolacca Decandra, Trigonella Foenum-graecum, Texas Tree, Texas Weed, Texas Grass
echinacea,baptisia tinctoria, hydrastis canadensis, myrrha, phytolacca decandra, trigonella foenum-graecum, texas tree, texas weed, texas grass
Non-Standardized Pollen Allergenic Extract [EPC]
Purpose: Relief from Sneezing, Runny Nose, Itchy Eyes and Sinus Congestion.*
Belatacept
belatacept
Selective T Cell Costimulation Blocker [EPC]
11 DESCRIPTION NULOJIX ® (belatacept), a selective T cell costimulation blocker, is a soluble fusion protein consisting of the modified extracellular domain of CTLA-4 fused to a portion (hinge-CH2-CH3 domains) of the Fc domain of a human immunoglobulin G1 antibody. Belatacept is produced by recombinant DNA technology in a mammalian cell expression system. Two amino acid substitutions (L104 to E; A29 to Y) were made in the ligand binding region of CTLA-4.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.